Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival | Zendy

Mari M. Kitahata | Zendy; Stephen J. Gange | Zendy; Alison G. Abraham | Zendy; Barry Merriman | Zendy; Michael S. Saag | Zendy; Amy C. Justice | Zendy; Robert S. Hogg | Zendy; Steven G. Deeks | Zendy; Joseph J. Eron | Zendy; John T. Brooks | Zendy; Sean B. Rourke | Zendy; M. John Gill | Zendy; Ronald J. Bosch | Zendy; Jeffrey N. Martin | Zendy; Marina B. Klein | Zendy; Lisa P. Jacobson | Zendy; Benigno Rodríguez | Zendy; Timothy R. Sterling | Zendy; Gregory D. Kirk | Zendy; Sonia Napravnik | Zendy; Anita Rachlis | Zendy; Liviana Calzavara | Zendy; Michael A. Horberg | Zendy; Michael J. Silverberg | Zendy; Kelly A. Gebo | Zendy; James J. Goedert | Zendy; Constance A. Benson | Zendy; Ann C. Collier | Zendy; Stephen E. Van Rompaey | Zendy; Heidi M. Crane | Zendy; Rosemary G. McKaig | Zendy; Bryan Lau | Zendy; Aimee Freeman | Zendy; Richard D. Moore | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

Author(s) -

Mari M. Kitahata,

Stephen J. Gange,

Alison G. Abraham,

Barry Merriman,

Michael S. Saag,

Amy C. Justice,

Robert S. Hogg,

Steven G. Deeks,

Joseph J. Eron,

John T. Brooks,

Sean B. Rourke,

M. John Gill,

Ronald J. Bosch,

Jeffrey N. Martin,

Marina B. Klein,

Lisa P. Jacobson,

Benigno Rodríguez,

Timothy R. Sterling,

Gregory D. Kirk,

Sonia Napravnik,

Anita Rachlis,

Liviana Calzavara,

Michael A. Horberg,

Michael J. Silverberg,

Kelly A. Gebo,

James J. Goedert,

Constance A. Benson,

Ann C. Collier,

Stephen E. Van Rompaey,

Heidi M. Crane,

Rosemary G. McKaig,

Bryan Lau,

Aimee Freeman,

Richard D. Moore

Publication year - 2009

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa0807252

Subject(s) - medicine , antiretroviral therapy , asymptomatic , cohort , confidence interval , human immunodeficiency virus (hiv) , relative risk , surgery , viral load , immunology

The optimal time for the initiation of antiretroviral therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection is uncertain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research